Trexquant Investment’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-402,790
Closed -$2.41M 2136
2026
Q1
$2.41M Buy
+402,790
New +$3.03M 0.02% 924
2025
Q4
Sell
-690,664
Closed -$7.38M 1832
2025
Q3
$7.38M Buy
+690,664
New +$6.78M 0.08% 398
2024
Q4
Sell
-42,748
Closed -$818K 1770
2024
Q3
$818K Sell
42,748
-32,495
-43% -$674K 0.01% 1106
2024
Q2
$1.56M Sell
75,243
-254,903
-77% -$5.07M 0.02% 836
2024
Q1
$6.21M Buy
330,146
+141,314
+75% +$2.43M 0.12% 236
2023
Q4
$2.72M Sell
188,832
-93,795
-33% -$1.28M 0.06% 459
2023
Q3
$4.91M Buy
+282,627
New +$5.89M 0.12% 241
2023
Q2
Sell
-49,647
Closed -$1.17M 1691
2023
Q1
$1.17M Buy
+49,647
New +$1.33M 0.03% 673
2022
Q1
Sell
-40,081
Closed -$1.22M 1620
2021
Q4
$1.22M Buy
+40,081
New +$1.31M 0.08% 334

Other funds holding OGN

Trexquant Investment's OGN Position: Q2 2026 in Review

Trexquant Investment sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 402,790 shares — an estimated $2.41M sold.

Trexquant Investment first reported a position in OGN in Q4 2021 and held it in 9 quarters. The position peaked at $7.38M in Q3 2025. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Trexquant Investment reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 402,790 Organon & Co shares in Q2 2026, an estimated $2.41M.
  • Trexquant Investment first reported a position in Organon & Co in Q4 2021 and held it in 9 quarters.
  • Trexquant Investment's Organon & Co position peaked at $7.38M in Q3 2025.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.